Skip to main content

PEAK6 LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1389958 AUSTIN, TX

Position in CRSP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,217,114
-$3,949,178 QoQ
Shares Held
22,316
-79.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#155
of 505 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Jun 30, 2026
CallValue
$3,834,162
CallShares
70,300
PutValue
$11,633,382
PutShares
213,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PEAK6 LLC holds $19,544,893 across 28 Biotechnology names. CRSP ranks #6 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 CRSP
CRISPR Therapeutics AG
This page
22,316 $1,217,114

All Filings in CRSP

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,834,162 70,300
2026-06-30 $11,633,382 213,300
2026-06-30 $1,217,114 22,316
2026-03-31 $14,075,963 295,900
2026-03-31 $5,166,292 108,604
2026-03-31 $3,386,984 71,200
2025-12-31 $1,445,980 27,574
2025-12-31 $14,394,780 274,500
2025-12-31 $3,613,116 68,900
2025-09-30 $24,050,991 371,100
2025-09-30 $10,654,764 164,400
2025-06-30 $19,266,304 396,100
2025-06-30 $18,984,192 390,300
2025-03-31 $16,266,340 478,000
2025-03-31 $2,169,378 63,749
2025-03-31 $11,015,511 323,700
2024-12-31 $535,296 13,600
2024-12-31 $2,896,896 73,600